TEMPRIAN THERAPEUTICS, INC. — Form D
TEMPRIAN THERAPEUTICS, INC. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-19. The offering totals $325K, of which $275K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-11-19
- Form: D
- Accession: 0001793774-19-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $325K
- Amount sold: $275K
- Remaining: $50K
- Investors: 1
- Date of first sale: 2019-01-25
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-353694
Issuer
- Name: TEMPRIAN THERAPEUTICS, INC.
- CIK: 0001793774
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2155 N BELL AVENUE, CHICAGO, IL, 60647
- Phone: 5133741180
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Kettil Cedercreutz | Director | Chicago, IL |
| Isabelle Caroline Le Poole | Director | Chicago, IL |
| Kettil Cedercreutz | Executive Officer | Chicago, IL |
| Isabelle Caroline Le Poole | Executive Officer | Chicago, IL |
More